Researchers working hard to develop potential drugs to help quit smoking

Are you trying hard to quit Smoking but you can’t? Although smoking is an addiction, people can quit smoking and soon we may have a potential drug that can help to quit smoking.

A new research has been published in the Journal of Medicinal Chemistry. Researchers discovery based on the liver enzyme called CYP2A6, that is responsible for metabolizes nicotine.  According to researchers, the people who have fewer copies of a gene for the enzyme tend to smoke less and are less likely to be addicted to smoking.

With these new potential drugs, people can quit smoking and this will be a great news for the persons who want to quit smoking. More than a dozen persons who are addicted to smoking were given the drugs to check its potential to curb smokers’ desire for nicotine by slowing how it is broken down in the body. Researchers hoped that the substances could help people reduce their consumption of tobacco, if not quit altogether.

The discovery targets a liver enzyme, called CYP2A6, which metabolizes nicotine. Researchers found that people who have fewer copies of a gene for the enzyme tend to smoke less and are less likely to be addicted to smoking.

Nicotine triggers the release of dopamine and serotonin, two pleasure-causing chemicals produced by the body. But as it gets metabolized, users can experience withdrawal symptoms like tingling in the hands and feet, sweating, anxiety, and irritability.

They also designed dozens of molecules that bind to CYP2A6 and inhibit its ability to metabolize nicotine.  Philip Lazarus, co-author of the study said that If you inhibit CYP2A6, it shouldn’t bother your overall health. If we could specifically target this enzyme, people should be fine, and it will possibly help them stop smoking or at least decrease their amount of smoking.

So far, the researchers have tested their candidate drugs to make sure they don’t disrupt other major enzymes that help the body metabolize other substances. This helped narrow the number of potential drugs down to 18.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit